98 related articles for article (PubMed ID: 12121679)
1. Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy.
Nishimura M; Matsuoka M; Maeda M; Mizuta I; Mita S; Uchino M; Matsui M; Kuroda Y; Kawakami H; Kaji R; Adachi A; Uchiyama T
Hum Immunol; 2002 Aug; 63(8):696-700. PubMed ID: 12121679
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy.
Nishimura M; Maeda M; Matsuoka M; Mine H; Saji H; Matsui M; Kuroda Y; Kawakami H; Uchiyama T
Hum Immunol; 2000 Dec; 61(12):1262-9. PubMed ID: 11163081
[TBL] [Abstract][Full Text] [Related]
3. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals.
Gadelha SR; Junior Alcântara LC; Costa GC; Acosta AX; Rios D; Kashima S; Covas DT; Galvão-Castro B
J Med Virol; 2008 Dec; 80(12):2141-6. PubMed ID: 19040291
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Sabouri AH; Saito M; Lloyd AL; Vine AM; Witkover AW; Furukawa Y; Izumo S; Arimura K; Marshall SE; Usuku K; Bangham CR; Osame M
J Infect Dis; 2004 Oct; 190(7):1279-85. PubMed ID: 15346339
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.
Rocha-Júnior MC; Haddad R; Cilião Alves DC; de Deus Wagatsuma VM; Mendes-Junior CT; Deghaide NH; Takayanagui OM; Covas DT; Donadi EA; Kashima S
Tissue Antigens; 2012 Aug; 80(2):143-50. PubMed ID: 22587568
[TBL] [Abstract][Full Text] [Related]
6. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
7. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
[TBL] [Abstract][Full Text] [Related]
8. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
[TBL] [Abstract][Full Text] [Related]
11. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene.
Vallinoto AC; Santana BB; Sá KS; Ferreira TC; Sousa RC; Azevedo VN; Feitosa RN; Machado LF; Ishak MO; Ishak R
Mediators Inflamm; 2015; 2015():804167. PubMed ID: 26609200
[TBL] [Abstract][Full Text] [Related]
13. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
14. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
15. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
Saito M; Eiraku N; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2005 May; 232(1-2):29-35. PubMed ID: 15850579
[TBL] [Abstract][Full Text] [Related]
16. Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.
Treviño A; Lopez M; Vispo E; Aguilera A; Ramos JM; Benito R; Roc L; Eiros JM; de Mendoza C; Soriano V;
Clin Infect Dis; 2012 Jul; 55(1):e1-4. PubMed ID: 22460962
[TBL] [Abstract][Full Text] [Related]
17. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy.
Watanabe H; Nakamura T; Nagasato K; Shirabe S; Ohishi K; Ichinose K; Nishiura Y; Chiyoda S; Tsujihata M; Nagataki S
Arch Neurol; 1995 Mar; 52(3):276-80. PubMed ID: 7872881
[TBL] [Abstract][Full Text] [Related]
18. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
Sarkis S; Belrose G; Peloponese JM; Olindo S; Césaire R; Mesnard JM; Gross A
J Clin Virol; 2013 Sep; 58(1):295-8. PubMed ID: 23756056
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
20. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
